Palvella Share Price

Palvella Share Price

NASDAQ: PVLA | Small Cap | Healthcare
$143.04
-$3.59 (-2.44%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Palvella Stock Performance

Open
$147.28
Prev. Close
$146.63
Circuit Range
N/A
Day Range
$142.23 - $147.42
Year Range
$72.35 - $179.95
Volume
11,440
Average Traded
$144.92

Palvella Share Price Today

As of 22 November 2026, Palvella Therapeutics, Inc.'s share price is $143.04. The stock opened at $147.28, compared to its previous close of $146.63. During today's trading session, Palvella Therapeutics, Inc.'s share price traded between $142.23 and $147.42, with an average price of $144.82. Over the past 52 weeks, the stock has recorded a high of $179.95 and a low of $72.35. In terms of performance, Palvella Therapeutics, Inc.'s share price has risen by 21.10% over the last six months and is up 38.49% on a year-on-year basis.

Palvella Share Price Chart

Line chart of the Palvella price trend over the selected period. The price fell overall, ranging from 142.24 to 148.67, ending at 143.06.
$142.23$147.42
L
Show Current Price
H

Palvella Stock Fundamentals & Key Indicators

Market Cap
$1.61B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-5.13
Revenue (TTM)
$0.00
Return On Equity (TTM)
-37.89%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-93.86%

Palvella Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$12.71-$15.77-$21.87-$24.64
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-24.08%-38.68%-12.67%

Palvella Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.00$0.00
Net Profit-$17.43-$41.72
Net Profit MarginN/AN/A
Income ChangeN/A-139.36%

Palvella Balance Sheet

All figures in USD Million

Particulars20252024
Non Current Assets0.570.0
Current Assets58.9988.23
Total Assets59.5688.23
Non Current Liabilities20.2313.59
Current Liabilities11.3412.04
Total Liabilities31.5825.63
Shareholders' Equity27.9862.61

Palvella Cash Flow

Annually
Particulars20252024
Operating (USD Million)-25.01-10.84
Investing (USD Billion)0.00.0
Financing (USD Million)-0.6687.09

About Palvella

Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company whose vision is to become the rare disease biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no FDA-approved therapies. Its product candidate, QTORIN 3.9% rapamycin anhydrous gel, is currently in clinical development for microcystic lymphatic malformations and cutaneous venous malformations. It operates in single segment.

Palvella Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$146.00
$142.59
-2.28%
Oct 2026
$134.99
$145.93
+4.03%
Sep 2026
$150.16
$140.28
-6.57%
Aug 2026
$137.99
$150.14
+7.82%
Jul 2026
$149.11
$139.25
-9.06%
Jun 2026
$115.47
$153.13
+29.64%
May 2026
$129.47
$118.12
-7.93%
Apr 2026
$129.50
$128.30
+2.64%
Mar 2026
$139.98
$125.00
-7.84%
Feb 2026
$78.81
$135.63
+76.90%
Jan 2026
$100.00
$76.67
-26.39%
Dec 2025
$96.25
$104.16
+0.84%

Palvella Share Price FAQs